Emergency Line: (002) 01061245741
Mon - Fri: 8.00am - 7.00pm

Get In Touch:

Get In Touch:

Pharmaceutical Product Registration in Lesotho

Registration of Pharmaceuticals/Medicine

  • Registration Requirement: No person is permitted to sell, manufacture, distribute, dispense, import, export, or handle a medicine or medical device unless it is registered with the Board, and the person is issued a license by the Board.
  • Application Submission: Anyone wishing to register a medicine or medical device with the Authority must submit an application for registration as prescribed by regulations determined by the Minister. The application must be accompanied by:
    1. On the safety, quality, and therapeutic efficacy of the medicine or medical device.
    2. A sample of the medicine or medical device, where appropriate.
    3. An application fee determined by the Minister.
  • Registration Criteria: The Board will register a medicine or medical device if:
    1. It is in the public interest.
    2. The medicine or medical device meets the required safety, quality, and therapeutic efficacy approved by the Board.
    3. The premises where the medicine or medical device is manufactured comply with current good manufacturing practices set by the Authority and are issued with the license.
    4. Any person handling the medicine or medical device is issued a license under section 29(3).
  • Application Processing: Within a minimum of 90 days of receiving an application, the Chief Executive Officer will submit the application with approved particulars, and where appropriate, with a sample medicine or medical device to the Board for consideration. The Board will:
    1. Undertake an investigation regarding the medicine or medical device.
    2. May inspect a manufacturing plant to ensure compliance with all conditions, requirements, and standards for registration.
    3. May request further or additional information relating to the application.
  • Approval of Registration: After considering an application, if the Board is satisfied that a medicine or medical device complies with the specified criteria, it will approve the registration with such terms and conditions as it deems necessary.
  • Notification of Approval: The Chief Executive Officer will inform the applicant within thirty days of receipt of the Board’s approval or disapproval of registration of a medicine or a medical device.

Completion of Registration: Upon approval of registration by the Board, the Chief Executive Officer will ensure the necessary completion procedures for the registration of the medicine or medical device.

(a) Registration Process: Upon approval, the Board shall register the medicine or the medical device and

(b) Certificate Issuance: issue a certificate of registration for the medicine or the medical device.

The medicine or the medical device will be registered under a name approved by the Board and assigned a registration number.

If the application is not approved by the Board, the applicant has the right to appeal. Within 30 days after disapproval, the applicant may lodge a written appeal to the Appeals Committee under section 43. The Authority is responsible for issuing guidelines on the manufacturing, import, and export of medicines and medical devices.

Offence and Penalties

Any person contravening subsection (1) commits an offence and, upon conviction, is liable to a fine not exceeding Fifty Thousand Maloti, imprisonment for a period not exceeding ten years, or both.

Prohibition of Sale of Unregistered Pharmaceuticals

No person is allowed to sell a medicine or medical device unless it is registered in accordance with Section 15 of the Act. However, the Minister, based on the Board’s recommendation and through a Gazette notice, may declare certain medicines or medical devices subject to registration in Lesotho. If such a declaration notice is issued, its effective date depends on whether the medicine or device was available for sale in Lesotho before the notice’s publication.

Sale of Unregistered Pharmaceuticals with Conditions

Despite the general prohibition, a person may sell an unregistered medicine or medical device if it was available in Lesotho before a declaration notice is published. In such cases, an application for registration must be submitted to the Board, along with payment of an application fee. The unregistered medicine or device can continue to be sold under certain conditions until the Board either approves the registration application, rejects it, prohibits its sale in Lesotho, the application is withdrawn, or it lapses.

Consequences of Contravening the Prohibition

Any person who sells an unregistered medicine or medical device in violation of the prohibition commits an offence. Upon conviction, they may be fined up to fifty thousand maloti, sentenced to imprisonment for a maximum of ten years, or both, according to the severity of the contravention.

Authorization and Regulation of Sale for Specified Use

The Board has the authority to authorize, in writing, the sale of a specified quantity of a particular medicine or medical device that is not registered, to a designated person or institution, for a specific period. However, such authorization comes with conditions set by the Board regarding the intended use and manner of use. The Board also has the power to withdraw this authorization if the medicine is not used as specified.

Renewal of Registration

A certificate of registration holder can apply for the renewal of the certificate for a medicine or a medical device six months before the original registration expires. The renewal application must be accompanied by the prescribed renewal fee.

Transfer of Certificate of Registration

The certificate of registration is transferable. If a certificate holder wishes to transfer it, an application must be submitted to the Board for approval to transfer it to another person eligible for the registration of a medicine or medical device. The application must be submitted in a form determined by the Minister, accompanied by a copy of the certificate to be transferred, and a transfer fee determined by the Minister.

Cancellation or Amendment of Registration

The Board has the authority to cancel or amend the registration of a medicine or medical device under various circumstances, including when it is not in the public interest, the retention fee is unpaid, the holder fails to comply with set conditions, the product no longer meets requirements, false advertisements, or non-compliance of manufacturing premises with set standards.

  • Before cancellation or amendment, the Board must:
    • Provide notice to the holder about the intention to cancel or amend.
    • Give the holder an opportunity to appear before the Board and present their case.
    • Specify the grounds for the proposed cancellation or amendment.
    • Allow the holder to provide reasons why the registration should not be cancelled or amended.
    • Direct the Chief Executive Officer to make necessary entries in the register if cancellation or amendment is deemed necessary.

Notification of Registration, Cancellation, or Amendment

The Minister is mandated to inform the public through Gazette notices about the registration, cancellation, or amendment of medicines or medical devices. For registered items, the notice details include the name, active components, applicant and manufacturer names, registration number, and any associated conditions. In cases of cancellation or variation, the notice includes the registered name, applicant name, and registration number.

Medicines Register

The register contains comprehensive information on various entities related to medicines and medical devices, such as registered medicines, complimentary medicines, medical devices, cosmetics, licensed individuals dealing with these products, licensed premises, nutraceuticals, and related substances. The Chief Executive Officer manages this register in electronic form.

Amendment and Cancellation of Entries

Any person can request changes or cancellations for a medicine entry in the register by submitting an application in a prescribed form along with a fee. The Chief Executive Officer forwards these applications to the Board for consideration. If approved, the Chief Executive Officer updates the register accordingly.

Retention Fee

Certificate holders are required to pay an annual retention fee for each registered medicine or medical device. The Minister determines the form and manner of payment, setting an annual fee applicable to all registered medicines or medical devices.

Purchase and Sale by Wholesalers

Wholesalers can only purchase medicines or medical devices from manufacturers or primary importers. They are authorized to sell these products to the retail sector or other wholesalers based on the authorized category of Schedules determined by the Board. If a product lacks safety, quality, or efficacy, the importer or wholesaler can return it to the manufacturer for a refund. Violation of this process is considered an offense.

Return of Undesirable Medicine and Medical Device

If the Board deems a medicine or medical device against public interest, it can direct individuals possessing such items to return them to the manufacturer or importer or deliver them to a designated person. Failure to comply with this directive is an offense, punishable by a fine, imprisonment, or both.

Licensing of Persons Handling Medicines or Medical Devices

No individual shall engage in manufacturing, dispensing, selling, distributing, or importing medicines or medical devices unless granted a license by the Board. Furthermore, the premises where these activities occur must meet the standards set by the Board. Licensing eligibility depends on qualifications and adherence to prescribed terms and conditions. Failure to comply constitutes an offense punishable by fines, imprisonment, or both.

Application for a License

Individuals seeking to manufacture, dispense, sell, distribute, or import medicines or medical devices must submit a written application to the Board. The Board may request additional information if necessary. Upon satisfaction of prescribed requirements and payment of fees, the Board issues a license within thirty days of receiving the application. 

For applications from registered companies, a shareholder and director must be a pharmacist and a citizen of Lesotho. The Board may refuse licenses that do not meet requirements, informing applicants in writing with reasons for refusal. Licenses are valid for one year and subject to renewal under previous terms and conditions.

Cancellation, Suspension, or Amendment of a License

Licenses may be cancelled, suspended, or amended if holders fail to comply with prescribed terms or if the Board deems it in the public interest. Holders dissatisfied with such decisions may appeal to the Appeals Committee against cancelation, suspension, or amendments, as well as conditions and requirements of issuance.

Importation and Exportation of Medicines or Medical Devices

Importing or exporting medicines or medical devices requires licensing under the Act or authorization by the Board for unregistered items. The container or package must bear labels in Sesotho or English, and the products must comply with quality, efficacy, and safety standards set by the Board. A certificate issued by the Board, upon payment of fees, is necessary for such importation or exportation. Failure to comply constitutes an offense punishable by fines, imprisonment, or both.

Post Marketing Surveillance and Safety Monitoring 

Pharmacovigilance Responsibilities of the Authority:

(1)The Authority shall

The Authority, as stipulated in this section, is tasked with comprehensive pharmacovigilance duties to ensure the safety and efficacy of medicines and medical devices regulated under this Act. These responsibilities include:

  1. Monitoring and Analysis: The Authority is required to actively monitor and analyze adverse effects or events associated with medicines and medical devices governed by the Act. This involves continuous surveillance to identify and understand any undesirable effects or incidents related to these products.
  2. Establishing Causality and Remedial Actions: In the event of adverse effects or events, the Authority is responsible for establishing causality, determining the link between the product and the observed effects. Subsequently, the Authority must take remedial actions to address the identified issues, ensuring the safety of patients and consumers.
  • Reporting to International Safety Monitoring System: The Authority is obligated to report relevant information on adverse effects and remedial actions to international safety monitoring systems. This contributes to a global network of surveillance and enables the sharing of critical safety data on medicines and medical devices.
  1. Regulatory Actions: The Authority has the authority to take appropriate regulatory actions when deemed necessary. These actions may include revising marketing authorizations, updating labelling requirements, or introducing additional warning specifications for medicines or medical devices. Such measures are crucial to maintain and enhance the safety standards of regulated products.

(2) The Authority shall issue guidelines to provide for mandatory reporting, submission of periodic safety updates by manufactures and distributors, and voluntary reporting by health professionals and the public.

Quality Monitoring

  • Risk-Based Testing Scheme: The Authority is empowered to implement a risk-based testing scheme, involving the sampling of medicines and medical devices across the entire supply chain. This scheme aims to identify products that are at the highest risk of being falsified or falling below-established quality standards. Subsequently, the Authority is mandated to take necessary actions to safeguard public health. These actions may include the enforcement of measures outlined in this Act to address identified risks and ensure the quality and safety of medical products in circulation.
  • Utilization of Accredited Laboratories: In the execution of its functions, the Authority is required to utilize the services of the National Pharmaceutical Quality Control Laboratory or any accredited laboratory, whether situated within or outside the country. This utilization is specifically for the analysis of medicines and medical devices. Accredited laboratories play a crucial role in objectively assessing the quality, safety, and efficacy of these products. By leveraging such facilities, the Authority can ensure a robust and scientifically rigorous evaluation process, contributing to the overall effectiveness of the quality monitoring system.

Recall, non-release or non-dispensation of a medicine:

In situations where the Board determines that a medicine or medical device is not suitable for consumption, it initiates a series of actions. These actions are directed towards safeguarding public health and include causing the Minister to declare, through a public notice published in the Gazette, that the affected medicine or medical device:

  1. Is Prohibited for Sale: The product is officially banned from being sold to the public. This measure is taken to prevent further distribution of unfit medicine or medical device, ensuring that consumers are not exposed to potential harm.
  2. Recall from the Market: If the identified product is already available for sale to the public, the Board recommends its recall from the market. This recall aims to retrieve the potentially harmful items and prevent their continued circulation among consumers.
  3. Return to Manufacturer: The Board may direct the return of the identified medicine or medical device to the manufacturer. This action is part of the effort to remove the substandard or unsafe products from the market and address the issue at its source.
  4. Prescribed Disposal: In cases were returning to the manufacturer is not practical or feasible, the Board may prescribe a specific manner of disposal. This ensures that the unfit medicine or medical device is safely and appropriately disposed of, preventing any further risk to public health.

Enquiry Now


    This will close in 0 seconds